The new formulation combines components widely sought after for their specific roles in dermatological health. Botulinum Peptide supports a refined skin appearance, while GHK-Cu provides conditioning benefits. Succinic Acid offers antioxidant properties alongside PDRN and Exosomes, both of which are utilized in advanced rejuvenation and recovery protocols. This release follows the international success of the HYALMASS AQUA EXOSOME line.

As the aesthetic market becomes increasingly crowded with products mimicking popular ingredient profiles and branding, MAYPHARM is urging distributors and consumers to exercise caution. The company emphasizes the necessity of verifying authorized supply channels and official packaging to ensure product authenticity. By consolidating these five active ingredients into one, the firm aims to streamline professional aesthetic procedures while reinforcing its market position against unauthorized imitations.